Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery (INCREASE)
Heart Valve Diseases
About this trial
This is an interventional treatment trial for Heart Valve Diseases focused on measuring randomized controlled trial, enhanced recovery after surgery, minimally invasive surgery, postanesthesia care unit, physiotherapy
Eligibility Criteria
Inclusion Criteria:
- Indication for elective minimally invasive (open) aortic or mitral valve surgery
- Patient's ability to understand the nature and extent of the individual's requirements for participation in the new care setting
- Classification of the patient as "FIT" or "Pre-FRAIL" using the LUCAS functional index (frailty index) (Dapp et al. 2012)
Exclusion Criteria:
- Limited life expectancy less than one year (e.g., advanced tumor disease)
- Urgent or emergency interventions
- Severe chronic obstructive pulmonary disease (GOLD III or IV)
- Dialysis-dependant renal failure
- Advanced liver cirrhosis (Child stages B + C)
- Severe comorbidities or psychosocial reasons that militate against participation or do not allow for written informed consent (e. g., residual neurological impairment after prior stroke, major restrictions of mobility, neuropsychological disorders, depressive disorder, substance-related addictive disorders)
- Lack of a social environment that can provide supportive patient care
- Previous cardiac surgery (i.e., relative contraindication for minimally invasive technique)
Sites / Locations
- Universitätsklinikum Augsburg
- Universitätsklinikum Hamburg-EppendorfRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ERAS protocol (intervention group)
Treatment as usual (control group)
The innovative care process in the intervention group is characterized by an interdisciplinary approach according to the previously established enhanced recovery after surgery protocol. This process aims at improving the clinical outcome after cardiac surgery, increasing patient satisfaction and quality of life, enabling early professional reentry and participation, and optimizing the cost-effectiveness of service provision. In addition, intersectoral barriers are being broken down in order to establish an interdisciplinary and cross-sectoral overall care process for patients with heart valve surgery as a new form of care in the future.
The control group undergoes standard heart valve surgery. In this case, no preoperative interventions take place, the patient is operated on the affected heart valve in a minimally invasive procedure without prehabilitation. After surgery, the patient is transfered to an intensive care unit (not a specialized postanesthesia care unit) depending on the individual condition and then transfered to the general ward. Patients receive medical, nursing, and physiotherapeutic care in accordance with current hospital standards.